» Articles » PMID: 35241789

Chromosome-scale Echinococcus Granulosus (genotype G1) Genome Reveals the Eg95 Gene Family and Conservation of the EG95-vaccine Molecule

Abstract

Cystic echinococcosis is a socioeconomically important parasitic disease caused by the larval stage of the canid tapeworm Echinococcus granulosus, afflicting millions of humans and animals worldwide. The development of a vaccine (called EG95) has been the most notable translational advance in the fight against this disease in animals. However, almost nothing is known about the genomic organisation/location of the family of genes encoding EG95 and related molecules, the extent of their conservation or their functions. The lack of a complete reference genome for E. granulosus genotype G1 has been a major obstacle to addressing these areas. Here, we assembled a chromosomal-scale genome for this genotype by scaffolding to a high quality genome for the congener E. multilocularis, localised Eg95 gene family members in this genome, and evaluated the conservation of the EG95 vaccine molecule. These results have marked implications for future explorations of aspects such as developmentally-regulated gene transcription/expression (using replicate samples) for all E. granulosus stages; structural and functional roles of non-coding genome regions; molecular 'cross-talk' between oncosphere and the immune system; and defining the precise function(s) of EG95. Applied aspects should include developing improved tools for the diagnosis and chemotherapy of cystic echinococcosis of humans.

Citing Articles

Designing of a multiepitope-based vaccine against echinococcosis utilizing the potent Ag5 antigen: Immunoinformatics and simulation approaches.

Parvin R, Masum M, Heema H, Akter A, Hossain M, Siddiki A PLoS One. 2025; 20(2):e0310510.

PMID: 39937717 PMC: 11819600. DOI: 10.1371/journal.pone.0310510.


Echinococcus granulosus sensu lato control measures: a specific focus on vaccines for both definitive and intermediate hosts.

Borhani M, Fathi S, Harandi M, Casulli A, Ding J, Liu M Parasit Vectors. 2024; 17(1):533.

PMID: 39716337 PMC: 11665232. DOI: 10.1186/s13071-024-06581-2.


Highly resolved genome assembly and comparative transcriptome profiling reveal genes related to developmental stages of tapeworm .

Nazarizadeh M, Novakova M, Drabkova M, Catchen J, Olson P, Stefka J Proc Biol Sci. 2024; 291(2015):20232563.

PMID: 38290545 PMC: 10827431. DOI: 10.1098/rspb.2023.2563.


Cystic echinococcosis in Iceland: a brief history and genetic analysis of a 46-year-old isolate collected prior to the eradication of this zoonotic disease.

Saarma U, Skirnisson K, Bjornsdottir T, Laurimae T, Kinkar L Parasitology. 2023; 150(7):638-643.

PMID: 37161714 PMC: 10261677. DOI: 10.1017/S0031182023000355.


The redlegged earth mite draft genome provides new insights into pesticide resistance evolution and demography in its invasive Australian range.

Thia J, Korhonen P, Young N, Gasser R, Umina P, Yang Q J Evol Biol. 2022; 36(2):381-398.

PMID: 36573922 PMC: 10107102. DOI: 10.1111/jeb.14144.

References
1.
McManus D, Zhang W, Li J, Bartley P . Echinococcosis. Lancet. 2003; 362(9392):1295-304. DOI: 10.1016/S0140-6736(03)14573-4. View

2.
Brunetti E, Kern P, Vuitton D . Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2009; 114(1):1-16. DOI: 10.1016/j.actatropica.2009.11.001. View

3.
McManus D, Gray D, Zhang W, Yang Y . Diagnosis, treatment, and management of echinococcosis. BMJ. 2012; 344:e3866. DOI: 10.1136/bmj.e3866. View

4.
Lightowlers M . Cysticercosis and echinococcosis. Curr Top Microbiol Immunol. 2012; 365:315-35. DOI: 10.1007/82_2012_234. View

5.
Craig P, Hegglin D, Lightowlers M, Torgerson P, Wang Q . Echinococcosis: Control and Prevention. Adv Parasitol. 2017; 96:55-158. DOI: 10.1016/bs.apar.2016.09.002. View